Free Trial

Yield10 Bioscience (YTEN) Stock Price, News & Analysis

-0.19 (-8.26%)
(As of 05/24/2024 03:48 PM ET)
Today's Range
50-Day Range
52-Week Range
11,100 shs
Average Volume
169,482 shs
Market Capitalization
$1.35 million
P/E Ratio
Dividend Yield
Price Target

Yield10 Bioscience MarketRank™ Stock Analysis

Analyst Rating
2.33 Rating Score
3,881.0% Upside
$84.00 Price Target
Short Interest
0.47% of Float Sold Short
Dividend Strength
News Sentiment
0.08mentions of Yield10 Bioscience in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.35 out of 5 stars

YTEN stock logo

About Yield10 Bioscience Stock (NASDAQ:YTEN)

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

YTEN Stock Price History

YTEN Stock News Headlines

Yield10 Bioscience Announces Delisting from Nasdaq
Yield10 Bioscience Sets 1-for-24 Reverse Stock Split
Q4 2023 Yield10 Bioscience Inc Earnings Call
Yield10 Bioscience: Q4 Earnings Insights
Dow Jumps 200 Points; US Weekly Jobless Claims Fall
Why Is Yield10 (YTEN) Stock Up 117% Today?
Yield10 Bioscience Inc.
See More Headlines
Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Agricultural production - crops
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
($5.16) per share


Free Float
Market Cap
$1.35 million
Not Optionable

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Oliver P. Peoples Ph.D. (Age 66)
    Co-Founder, President, CEO & Director
    Comp: $344.48k
  • Dr. Anthony J. Sinskey Ph.D. (Age 84)
    Sc.D., Co-Founder & Independent Director
    Comp: $62.5k
  • Dr. Kristi D. Snell (Age 56)
    VP of Research & Chief Science Officer
    Comp: $278.69k
  • Ms. Lynne H. Brum (Age 60)
    VP of Planning & Corporate Communications and Secretary
    Comp: $278.69k
  • Mr. Charles B. HaaserMr. Charles B. Haaser (Age 68)
    VP of Finance, Chief Accounting Officer & Treasurer
    Comp: $236.41k
  • Dr. Nicholas Renegar Ph.D.
    Director of Business Analytics & Operations

YTEN Stock Analysis - Frequently Asked Questions

Should I buy or sell Yield10 Bioscience stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" YTEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in YTEN, but not buy additional shares or sell existing shares.
View YTEN analyst ratings
or view top-rated stocks.

What is Yield10 Bioscience's stock price target for 2024?

3 Wall Street analysts have issued twelve-month target prices for Yield10 Bioscience's shares. Their YTEN share price targets range from $72.00 to $96.00. On average, they anticipate the company's share price to reach $84.00 in the next twelve months. This suggests a possible upside of 3,881.0% from the stock's current price.
View analysts price targets for YTEN
or view top-rated stocks among Wall Street analysts.

How have YTEN shares performed in 2024?

Yield10 Bioscience's stock was trading at $5.7432 at the beginning of the year. Since then, YTEN stock has decreased by 63.3% and is now trading at $2.11.
View the best growth stocks for 2024 here

When is Yield10 Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our YTEN earnings forecast

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced its quarterly earnings results on Monday, April, 1st. The specialty chemicals company reported ($6.48) EPS for the quarter.

When did Yield10 Bioscience's stock split?

Yield10 Bioscience's stock reverse split on Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD).

How do I buy shares of Yield10 Bioscience?

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:YTEN) was last updated on 5/27/2024 by Staff

From Our Partners